Shoshana KerenLin Med Ctr Carmel Hosp关注立即认领分享关注立即认领分享基本信息浏览量:0职业迁徙个人简介暂无内容研究兴趣论文共 2 篇作者统计合作学者相似作者按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选时间引用量主题期刊级别合作者合作机构dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50%Liran Holtzman,Mor Moskovitz,Damien Urban,Hovav Nechushtan,Shoshana Keren, Daniel Reinhorn,Mira Wollner,Sameh Daher,Yakir Rottenberg, Yulia Rovitzky,Tzippy Shochat,Jair Bar,Clinical Lung Cancer(2022)引用7浏览0WOS引用70Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life CohortElizabeth Dudnik,Jair Bar,Nir Peled,Elias Bshara, Teodor Kuznetsov, Aharon Yonathan Cohen,Tzippy Shochat,Hovav Nechushtan,Amir Onn,Abed Agbarya,Mor Moskovitz,Shoshana Keren,Clinical lung cancerno. 4 (2019): 278-286.e1引用9浏览0WOS引用90作者统计合作学者合作机构D-Core合作者学生导师暂无相似学者,你可以通过学者研究领域进行搜索筛选数据免责声明页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn